Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Comments on FDA Plausible Mechanism Draft Guidance
-
AMA Federation letter regarding the Ensuring Community Access to Pharmacist Services (ECAPS) Act
-
Sign-on Letter to Evicore Regarding Interpretation of NCCN Guidelines
-
Sign on letter concerning the Equitable Community Access to Pharmacist Services Act
-
Sign-on Letter Concerning the Equitable Community Access to Pharmacist Services Act
-
Stakeholder Letter Supporting Joint Resolutions to Overturn FDA Rule on LDTs
-
ACMG Response to Senate HELP Committee RFI on Diagnostics Regulation
-
ACMG Response to RFI on Gene Therapies Access for Rare Diseases
-
ACMG Comments on FDA Proposed Rule for Regulation of LDTs
-
Stakeholder Letter Asking Congress Renew Efforts on CLIA Reform and Urge FDA to Halt LDT Rulemaking